Schedule 13D ownership disclosure

AKARI THERAPEUTICS PLC

Ordinary Shares, $0.000000005 par value · CUSIP: 00972G207

Event date: 2026-03-02

Filing-level shares
9,725,215,000.00
Percent of class
10.4%
  • Samir R. PatelReported CIK 0001702447

    Shares: 9,725,215,000.00 · Class: 10.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-008874
Form type
SCHEDULE 13D/A
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Mar 04, 2026
Reporting period
Mar 02, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub